Target intelligence / Profile preview

Daboia siamensis phospholipase A2 (svPLA2)

Target
svPLA2
Molecular classification
Enzyme, Hydrolase, Secreted phospholipase A2, Toxin
01

Overview

Daboia siamensis phospholipase A2 toxins are a group of potent enzymes and proteins that serve as the primary toxic components in the venom of the Eastern Russell's viper [1, 4]. These toxins function as secreted phospholipases A2 (sPLA2), which catalyze the calcium-dependent hydrolysis of phospholipids in cellular membranes, leading to the release of fatty acids and lysophospholipids [2, 7]. This enzymatic process triggers a cascade of pathological events, including presynaptic neurotoxicity by blocking acetylcholine release, systemic myotoxicity, and severe acute kidney injury characterized by tubular necrosis [1, 5, 10]. Additionally, these toxins exhibit anticoagulant and pro-inflammatory properties that exacerbate the clinical severity of envenomation [3, 8]. Given their central role in the morbidity and mortality associated with Russell's viper bites, they are critical therapeutic targets for both traditional antibody-based antivenoms and emerging small-molecule inhibitors like varespladib [6, 7].

Other names
DaboiatoxinViperotoxin FRvPLA2dssPLA2Drs-PLA2Phosphatidylcholine 2-acylhydrolaseSnake venom phospholipase A2
02

Mechanism of action

Competitive inhibition of the phospholipase A2 active site and antibody-mediated neutralization of the toxin's enzymatic and non-enzymatic domains.

03

Biological functions

Lipid metabolismSignal transductionNeuromuscular transmission inhibitionInflammatory response induction
04

Disease associations

Snakebite envenomingAcute kidney injuryMyotoxicityNeurotoxicityCoagulopathy
05

Safety considerations

Irreversible nephrotoxicityRespiratory paralysisSystemic inflammatory response syndromeTissue necrosis
06

Interacting drugs

Varespladib

3 more in the full profile.

07

Biomarkers

Serum creatinineBlood urea nitrogenCreatine kinaseProthrombin time

Beyond the preview

Go deeper on Daboia siamensis phospholipase A2 (svPLA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia siamensis phospholipase A2 (svPLA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call